Jinfu J. Nie

No. 350, Shushan Hu Road
Hefei, 230031, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Correction: A targeted epigenetic clock for simultaneous assessment of biological aging and cancer-associated methylation drift.

Correction: A targeted epigenetic clock for simultaneous assessment of biological aging and cancer-associated methylation drift.

Journal: Clinical epigenetics

Published: July 08, 2026

A targeted epigenetic clock for simultaneous assessment of biological aging and cancer-associated methylation drift.

A targeted epigenetic clock for simultaneous assessment of biological aging and cancer-associated methylation drift.

Journal: Clinical epigenetics

Published: January 20, 2026

A TP53-Pathway-Based Prognostic Signature for Radiotherapy and Functional Validation of TP53I3 in Non-Small-Cell Lung Cancer.

A TP53-Pathway-Based Prognostic Signature for Radiotherapy and Functional Validation of TP53I3 in Non-Small-Cell Lung Cancer.

Journal: Cancers

Published: December 09, 2025

Identification of Trogocytosis as an Essential Limitation Factor in hPSC-derived CAR Macrophages.

Identification of Trogocytosis as an Essential Limitation Factor in hPSC-derived CAR Macrophages.

Journal: International journal of biological sciences

Published: October 28, 2025

Multi-output learning for systematic missing value imputation in DNA methylation arrays.

Multi-output learning for systematic missing value imputation in DNA methylation arrays.

Journal: Bioinformatics advances

Published: August 27, 2025

NEDD4 is a biomarker of a poor prognosis that contributes to the progression and chemoresistance in small cell lung cancer.

NEDD4 is a biomarker of a poor prognosis that contributes to the progression and chemoresistance in small cell lung cancer.

Journal: Cell cycle (Georgetown, Tex.)

Published: August 06, 2025

Cell-free DNA methylation and fragmentomics-based liquid biopsy for accurate esophageal cancer detection.

Cell-free DNA methylation and fragmentomics-based liquid biopsy for accurate esophageal cancer detection.

Journal: BMC cancer

Published: April 03, 2025

A comprehensive analysis of vasculogenic mimicry related genes to predict the survival rate of HCC and its influence on the tumor microenvironment.

A comprehensive analysis of vasculogenic mimicry related genes to predict the survival rate of HCC and its influence on the tumor microenvironment.

Journal: Frontiers in genetics

Published: May 24, 2024

Plasma cell-free DNA methylome-based liquid biopsy for accurate gastric cancer detection.

Plasma cell-free DNA methylome-based liquid biopsy for accurate gastric cancer detection.

Journal: Cancer science

Published: March 26, 2024

Cisplatin resistance-related transcriptome and methylome integration identifies PCDHB4 as a novel prognostic biomarker in small cell lung cancer.

Cisplatin resistance-related transcriptome and methylome integration identifies PCDHB4 as a novel prognostic biomarker in small cell lung cancer.

Journal: iScience

Published: November 10, 2023

CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer.

CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer.

Journal: BMC medical imaging

Published: October 11, 2023

The identification of a two-gene prognostic model based on cisplatin resistance-related ceRNA network in small cell lung cancer.

The identification of a two-gene prognostic model based on cisplatin resistance-related ceRNA network in small cell lung cancer.

Journal: BMC medical genomics

Published: December 12, 2022

Showing 1-12 of 40

Last Updated: 09/26/2026